PubMed=9331097
Salazar-Onfray F., Nakazawa T., Chhajlani V., Petersson M., Karre K., Masucci G., Celis E., Sette A., Southwood S., Appella E., Kiessling R.
Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells.
Cancer Res. 57:4348-4355(1997)

PubMed=10395702; DOI=10.4049/jimmunol.163.2.1037
Rongcun Y., Salazar-Onfray F., Charo J., Malmberg K.-J., Evrin K., Maes H., Kono K., Hising C., Petersson M., Larsson O., Lan L., Appella E., Sette A., Celis E., Kiessling R.
Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.
J. Immunol. 163:1037-1044(1999)

PubMed=11016658
Girnita L., Girnita A., Brodin B., Xie Y.-T., Nilsson G., Dricu A., Lundeberg J., Wejde J., Bartolazzi A., Wiman K.G., Larsson O.
Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.
Cancer Res. 60:5278-5283(2000)